Loading...
Channel Therapeutics Corporation
PTHS•NYSE
Healthcare
Biotechnology
$18.97
$2.50(15.18%)
Channel Therapeutics Corporation (PTHS) Quarterly Earnings Reports & Financial Results
Analyze Channel Therapeutics Corporation’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of Channel Therapeutics Corporation’s actual vs. estimated earnings across recent quarters.
No data available
Channel Therapeutics Corporation (PTHS) Quarterly Earnings Details
Detailed breakdown of Channel Therapeutics Corporation’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.